ES2070934T3 - Derivados de oxotremorina 3- o 4-sustituidos. - Google Patents

Derivados de oxotremorina 3- o 4-sustituidos.

Info

Publication number
ES2070934T3
ES2070934T3 ES90101248T ES90101248T ES2070934T3 ES 2070934 T3 ES2070934 T3 ES 2070934T3 ES 90101248 T ES90101248 T ES 90101248T ES 90101248 T ES90101248 T ES 90101248T ES 2070934 T3 ES2070934 T3 ES 2070934T3
Authority
ES
Spain
Prior art keywords
compounds
substituted
derivatives
oxotremorina
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90101248T
Other languages
English (en)
Inventor
Eugene John Trybulski
Richard Hermann Kramss
Herbert Joseph Brabander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2070934T3 publication Critical patent/ES2070934T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

ESTE DESCUBRIMIENTO DESCRIBE NUEVOS DERIVADOS DE 3 O 4 SUSTITUIDA OXOTREMORINA TENIENDO GRUPOS AZUFRE U OXIGENO POLAR SUSTITUIDOS. LOS COMPUESTOS TIENEN ACTIVIDAD COMO IMPULSORES NERVIOSOS. TAMBIEN SE DESCUBREN METODOS PARA TRATAR ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL EN MAMIFEROS EMPLEANDO LOS COMPUESTOS, PREPARACIONES FARMACEUTICAS CONTENIENDO LOS COMPUESTOS Y PROCESOS PARA LA PRODUCCION DE LOS COMPUESTOS.
ES90101248T 1989-01-23 1990-01-22 Derivados de oxotremorina 3- o 4-sustituidos. Expired - Lifetime ES2070934T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/300,447 US4937235A (en) 1989-01-23 1989-01-23 3- or 4-substituted oxotremorine derivatives

Publications (1)

Publication Number Publication Date
ES2070934T3 true ES2070934T3 (es) 1995-06-16

Family

ID=23159138

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90101248T Expired - Lifetime ES2070934T3 (es) 1989-01-23 1990-01-22 Derivados de oxotremorina 3- o 4-sustituidos.

Country Status (9)

Country Link
US (2) US4937235A (es)
EP (1) EP0381984B1 (es)
JP (1) JP2894358B2 (es)
AT (1) ATE121388T1 (es)
AU (1) AU622517B2 (es)
CA (1) CA2008107C (es)
DE (1) DE69018659T2 (es)
DK (1) DK0381984T3 (es)
ES (1) ES2070934T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089518A (en) * 1989-01-23 1992-02-18 American Cyanamid Company 3- or 4-substituted oxotremorine derivatives and a method of treating cholinergic dysfunction therewith
JP2834501B2 (ja) * 1989-11-25 1998-12-09 鐘淵化学工業株式会社 ３，４―エポキシ酪酸エステルの製法および中間体
US5550257A (en) * 1991-04-24 1996-08-27 American Cyanamid Company Substituted oxotremorine derivatives
US5356885A (en) * 1991-04-24 1994-10-18 American Cyanamid Company Substituted oxotremorine derivatives and pharmaceutical use thereof
US5346910A (en) * 1992-06-03 1994-09-13 American Cyanamid Company Maleimide derivatives of oxotremorine
US5932745A (en) * 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
KR100295740B1 (ko) 1998-09-17 2001-11-05 박영구 N-치환된-하이드록시고리화알킬아민유도체의제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1245743A (en) * 1967-11-09 1971-09-08 Astra Ab Alkynyl lactams
US3856790A (en) 1970-01-06 1974-12-24 American Home Prod Cyclic amides of 1,4-diaminobut-2-yne
EP0009326A3 (en) * 1978-08-30 1980-04-16 Pfizer Limited Pyrrolyl keto and amino acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
GR78370B (es) * 1981-12-24 1984-09-26 Delalande Sa
US4847284A (en) * 1988-03-23 1989-07-11 Merck & Co., Inc. Antifungal fermentation product and derivatives and compositions thereof
DE3835291A1 (de) * 1988-04-19 1989-11-02 Bayer Ag 1,3-disubstituierte pyrrolidine

Also Published As

Publication number Publication date
US4952600A (en) 1990-08-28
EP0381984B1 (en) 1995-04-19
CA2008107C (en) 1996-08-13
JP2894358B2 (ja) 1999-05-24
CA2008107A1 (en) 1990-07-23
JPH02229155A (ja) 1990-09-11
ATE121388T1 (de) 1995-05-15
DK0381984T3 (da) 1995-05-08
AU622517B2 (en) 1992-04-09
DE69018659T2 (de) 1996-01-18
US4937235A (en) 1990-06-26
DE69018659D1 (de) 1995-05-24
EP0381984A1 (en) 1990-08-16
AU4868490A (en) 1990-07-26

Similar Documents

Publication Publication Date Title
DE69017606T2 (de) Substituierte Cyclohexanole mit zentraler Nervensystemwirkung.
HUT43582A (en) Process for production of derivatives of 4,5,6-substituated-n-/substituated phenil/-piramidin-amin and medical compounds containing thereof
TW289020B (es)
DK314487A (da) Benzoxepinderivat
HUT45960A (en) Process for producing 2,4,5-trisubstituted derivatives of phenol of antiflogistic activity
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
ATE131056T1 (de) Verwendung von 2,3,4,5-tetrahydro-1h-3- benzazepinen bei der behandlung von neurologischen störungen.
ES2070934T3 (es) Derivados de oxotremorina 3- o 4-sustituidos.
NO176097C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte cykloheksener
DK0435177T3 (da) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler
DE3750271D1 (de) Substituierte Thiacycloalkeno [3,2-b] pyridine, Methode zur Herstellung, Zubereitungen und Methode zu ihrer Anwendung.
DK229984D0 (da) 4-oxothiazolidin-2-yliden-acetamid-derivater
ES2043896T3 (es) Procedimiento para la preparacion de derivados de tetrahidropiridina.
PT93822A (pt) Processo para a preparacao de derivados de piridina
DE3887174D1 (de) Verfahren zur Herstellung von 2,3-Dihydro-1H-imidazolylalkoxyinden-Derivaten und ihren pharmazeutisch annehmbaren Salzen, und Zwischenprodukte hierfür.
ATE49964T1 (de) Benzodioxepane, verfahren zur herstellung und verwendung als heilmittel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 381984

Country of ref document: ES